# Elevation Oncology Inc. (ELEV) Source: https://www.quantisnow.com/company/ELEV Generated: 2026-11-11T20:14:02.249Z - Ticker: ELEV - Exchange: NASDAQ - Sector: Health Care - Industry: Biotechnology: Biological Products (No Diagnostic Substances) - IPO year: 2021 - SEC CIK: 0002131124 ## Latest ELEV news and filings - 2025-08-04 20:34 UTC [SEC Form 15-12G filed by Elevation Oncology Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-elevation-oncology-inc-6145149) - 2025-07-29 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Elevation Oncology Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-elevation-oncology-inc-6135117) - 2025-07-29 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Elevation Oncology Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-elevation-oncology-inc-6135115) - 2025-07-28 18:18 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by Elevation Oncology Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-elevation-oncology-inc-6134204) - 2025-07-24 20:40 UTC [SEC Form 4] [SEC Form 4 filed by Director Sandler Alan B.](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-sandler-alan-b-6131947) - 2025-07-24 20:35 UTC [SEC Form 4] [SEC Form 4 filed by Director Mootz Darcy](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-mootz-darcy-6131919) - 2025-07-24 20:30 UTC [SEC Form 4] [SEC Form 4 filed by Director Elms Steve](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-elms-steve-6131863) - 2025-07-24 20:25 UTC [SEC Form 4] [SEC Form 4 filed by Director Clackson Timothy P](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-clackson-timothy-p-6131812) - 2025-07-24 20:20 UTC [SEC Form 4] [SEC Form 4 filed by Director Cherrington Julie M](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-cherrington-julie-m-6131775) - 2025-07-24 20:15 UTC [SEC Form 4] [SEC Form 4 filed by Director Carruthers R Michael](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-carruthers-r-michael-6131710) - 2025-07-24 20:10 UTC [SEC Form 4] [CHIEF FINANCIAL OFFICER Furlong Tammy closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-furlong-tammy-closing-all-direct-ownership-in-6131621) - 2025-07-23 20:20 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Elevation Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-elevation-oncology-inc-6129874) - 2025-07-23 20:20 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Elevation Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-elevation-oncology-inc-6129872) - 2025-07-23 20:20 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Elevation Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-elevation-oncology-inc-6129871) - 2025-07-23 20:20 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Elevation Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-elevation-oncology-inc-6129870) - 2025-07-23 20:20 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Elevation Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-elevation-oncology-inc-6129869) - 2025-07-23 20:15 UTC [SEC Form POS AM filed by Elevation Oncology Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-elevation-oncology-inc-6129840) - 2025-07-23 20:15 UTC [SEC Form POS AM filed by Elevation Oncology Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-elevation-oncology-inc-6129817) - 2025-07-23 17:48 UTC [SEC Form 25-NSE filed by Elevation Oncology Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-elevation-oncology-inc-6129475) - 2025-07-23 13:27 UTC [SEC Form 8-K] [Elevation Oncology Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/elevation-oncology-inc-filed-sec-form-8-k-completion-of-acquisition-6129345) - 2025-07-23 13:06 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by Elevation Oncology Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-elevation-oncology-inc-6129314) - 2025-07-02 20:15 UTC [SEC Form 8-K] [Elevation Oncology Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement](https://www.quantisnow.com/insight/elevation-oncology-inc-filed-sec-form-8-k-termination-of-a-6108391) - 2025-06-23 20:13 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9 filed by Elevation Oncology Inc.](https://www.quantisnow.com/insight/sec-form-sc-14d9-filed-by-elevation-oncology-inc-6095550) - 2025-06-23 14:22 UTC [SEC Schedule TOT] [SEC Form SC TO-T filed by Elevation Oncology Inc.](https://www.quantisnow.com/insight/sec-form-sc-to-t-filed-by-elevation-oncology-inc-6095197) - 2025-06-18 20:15 UTC [SEC Form 4] [CHIEF EXECUTIVE OFFICER Ferra Joseph J Jr converted options into 12,560 shares and covered exercise/tax liability with 4,627 shares, increasing direct ownership by 6% to 145,085 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-ferra-joseph-j-jr-converted-options-into-6091885) - 2025-06-09 20:30 UTC [SEC Form 4] [SEC Form 4 filed by Director Sandler Alan B.](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-sandler-alan-b-6078669) - 2025-06-09 20:25 UTC [SEC Form 4] [SEC Form 4 filed by Director Mootz Darcy](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-mootz-darcy-6078590) - 2025-06-09 20:20 UTC [SEC Form 4] [SEC Form 4 filed by Director Elms Steve](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-elms-steve-6078556) - 2025-06-09 20:15 UTC [SEC Form 4] [SEC Form 4 filed by Director Clackson Timothy P](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-clackson-timothy-p-6078471) - 2025-06-09 20:10 UTC [SEC Form 4] [SEC Form 4 filed by Director Cherrington Julie M](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-cherrington-julie-m-6078356) - 2025-06-09 20:05 UTC [SEC Form 4] [SEC Form 4 filed by Director Carruthers R Michael](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-carruthers-r-michael-6078218) - 2025-06-09 12:10 UTC [SEC Form SC14D9C filed by Elevation Oncology Inc.](https://www.quantisnow.com/insight/sec-form-sc14d9c-filed-by-elevation-oncology-inc-6077696) - 2025-06-09 12:05 UTC [SEC Form 8-K] [Elevation Oncology Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/elevation-oncology-inc-filed-sec-form-8-k-entry-into-a-6077692) - 2025-06-09 12:00 UTC [Elevation Oncology Enters into Agreement to Be Acquired by Concentra Biosciences for $0.36 in Cash per Share Plus a Contingent Value Right](https://www.quantisnow.com/insight/elevation-oncology-enters-into-agreement-to-be-acquired-by-concentra-6077667) - 2025-05-19 20:15 UTC [SEC Form 4] [CHIEF FINANCIAL OFFICER Furlong Tammy converted options into 2,643 shares and covered exercise/tax liability with 784 shares, increasing direct ownership by 23% to 10,075 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-furlong-tammy-converted-options-into-2643-shares-6047792) - 2025-05-19 20:10 UTC [SEC Form 4] [CHIEF EXECUTIVE OFFICER Ferra Joseph J Jr converted options into 6,250 shares and covered exercise/tax liability with 2,303 shares, increasing direct ownership by 3% to 137,152 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-ferra-joseph-j-jr-converted-options-into-6047714) - 2025-05-15 20:27 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Elevation Oncology Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-elevation-oncology-inc-6042850) - 2025-05-15 20:15 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Elevation Oncology Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-elevation-oncology-inc-6042509) - 2025-05-15 11:45 UTC [SEC Form 8-K] [Elevation Oncology Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/elevation-oncology-inc-filed-sec-form-8-k-results-of-operations-6040720) - 2025-05-15 11:30 UTC [Elevation Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates](https://www.quantisnow.com/insight/elevation-oncology-reports-first-quarter-2025-financial-results-and-provides-6040686) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ELEV - Earnings history: https://www.quantisnow.com/earnings/ELEV - Dividend history: https://www.quantisnow.com/dividends/ELEV - Insider transactions: https://www.quantisnow.com/insiders/ELEV - Options chain: https://www.quantisnow.com/options/ELEV - SEC 8-K filings only: https://www.quantisnow.com/company/ELEV/8-k - RSS and alerts for ELEV: https://www.quantisnow.com/docs/rss-feeds.md